142 related articles for article (PubMed ID: 11567993)
1. Membrane localization is not required for Mpl function in normal hematopoietic cells.
Otto KG; Broudy VC; Lin NL; Parganas E; Luthi JN; Drachman JG; Ihle JN; Blau CA
Blood; 2001 Oct; 98(7):2077-83. PubMed ID: 11567993
[TBL] [Abstract][Full Text] [Related]
2. Promegapoietin, a family of chimeric growth factors, supports megakaryocyte development through activation of IL-3 and c-Mpl ligand signaling pathways.
Doshi PD; Giri JG; Abegg AL; Favara JP; Huynh MS; Kahn LE; Minnerly JC; Pegg LE; Villani-Price D; Siegel NR; Staten NR; Thomas JW; McKearn JP; Smith WG
Exp Hematol; 2001 Oct; 29(10):1177-84. PubMed ID: 11602319
[TBL] [Abstract][Full Text] [Related]
3. Dissecting the thrombopoietin receptor: functional elements of the Mpl cytoplasmic domain.
Drachman JG; Kaushansky K
Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2350-5. PubMed ID: 9122198
[TBL] [Abstract][Full Text] [Related]
4. A novel MPL point mutation resulting in thrombopoietin-independent activation.
Abe M; Suzuki K; Inagaki O; Sassa S; Shikama H
Leukemia; 2002 Aug; 16(8):1500-6. PubMed ID: 12145691
[TBL] [Abstract][Full Text] [Related]
5. Thrombopoietin does not induce lineage-restricted commitment of Mpl-R expressing pluripotent progenitors but permits their complete erythroid and megakaryocytic differentiation.
Goncalves F; Lacout C; Villeval JL; Wendling F; Vainchenker W; Dumenil D
Blood; 1997 May; 89(10):3544-53. PubMed ID: 9160659
[TBL] [Abstract][Full Text] [Related]
6. A new feature of Mpl receptor: ligand-induced transforming activity in FRE rat fibroblasts.
Challier C; Cocault L; Flon M; Pauchard M; Porteu F; Gisselbrecht S; Souyri M
Oncogene; 2000 Apr; 19(16):2033-42. PubMed ID: 10803464
[TBL] [Abstract][Full Text] [Related]
7. Embryonic stem cell differentiation to hematopoietic cells: A model to study the function of various regions of the intracytoplasmic domain of cytokine receptors in vitro.
Filippi MD; Porteu F; Le Pesteur F; Rameau P; Nogueira MM; Debili N; Vainchenker W; de Sauvage FJ; Kupperschmitt AD; Sainteny F
Exp Hematol; 2000 Dec; 28(12):1363-72. PubMed ID: 11146158
[TBL] [Abstract][Full Text] [Related]
8. Involvement of prolonged ras activation in thrombopoietin-induced megakaryocytic differentiation of a human factor-dependent hematopoietic cell line.
Matsumura I; Nakajima K; Wakao H; Hattori S; Hashimoto K; Sugahara H; Kato T; Miyazaki H; Hirano T; Kanakura Y
Mol Cell Biol; 1998 Jul; 18(7):4282-90. PubMed ID: 9632812
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic-repopulating defects from STAT5-deficient bone marrow are not fully accounted for by loss of thrombopoietin responsiveness.
Bradley HL; Couldrey C; Bunting KD
Blood; 2004 Apr; 103(8):2965-72. PubMed ID: 15070672
[TBL] [Abstract][Full Text] [Related]
10. Studies with chimeric Mpl/JAK2 receptors indicate that both JAK2 and the membrane-proximal domain of Mpl are required for cellular proliferation.
Drachman JG; Miyakawa Y; Luthi JN; Dahlen DD; Raney A; Geddis AE; Kaushansky K
J Biol Chem; 2002 Jun; 277(26):23544-53. PubMed ID: 11980901
[TBL] [Abstract][Full Text] [Related]
11. The cytoplasmic domain of Mpl receptor transduces exclusive signals in embryonic and fetal hematopoietic cells.
Challier C; Cocault L; Berthier R; Binart N; Dusanter-Fourt I; Uzan G; Souyri M
Blood; 2002 Sep; 100(6):2063-70. PubMed ID: 12200367
[TBL] [Abstract][Full Text] [Related]
12. Alteration of c-mpl-mediated signal transduction in CD34(+) cells from patients with myelodysplastic syndromes.
Kalina U; Hofmann WK; Koschmieder S; Wagner S; Kauschat D; Hoelzer D; Ottmann OG
Exp Hematol; 2000 Oct; 28(10):1158-63. PubMed ID: 11027834
[TBL] [Abstract][Full Text] [Related]
13. The thrombopoietin receptor c-MPL activates JAK2 and TYK2 tyrosine kinases.
Sattler M; Durstin MA; Frank DA; Okuda K; Kaushansky K; Salgia R; Griffin JD
Exp Hematol; 1995 Aug; 23(9):1040-8. PubMed ID: 7543416
[TBL] [Abstract][Full Text] [Related]
14. Establishment and characterization of the thrombopoietin-dependent megakaryocytic cell line, UT-7/TPO.
Komatsu N; Kunitama M; Yamada M; Hagiwara T; Kato T; Miyazaki H; Eguchi M; Yamamoto M; Miura Y
Blood; 1996 Jun; 87(11):4552-60. PubMed ID: 8639823
[TBL] [Abstract][Full Text] [Related]
15. Thrombopoietin signaling is required for in vivo expansion of IL-11--responsive hematopoietic progenitor cells in the steady state.
Scott CL; Robb L; Nandurkar HH; Mansfield R; Alexander WS; Begley CG
Exp Hematol; 2001 Feb; 29(2):138-45. PubMed ID: 11166452
[TBL] [Abstract][Full Text] [Related]
16. Identification of an oncogenic form of the thrombopoietin receptor MPL using retrovirus-mediated gene transfer.
Onishi M; Mui AL; Morikawa Y; Cho L; Kinoshita S; Nolan GP; Gorman DM; Miyajima A; Kitamura T
Blood; 1996 Aug; 88(4):1399-406. PubMed ID: 8695859
[TBL] [Abstract][Full Text] [Related]
17. Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis.
Tong W; Lodish HF
J Exp Med; 2004 Sep; 200(5):569-80. PubMed ID: 15337790
[TBL] [Abstract][Full Text] [Related]
18. Expansion of genetically modified primary human hemopoietic cells using chemical inducers of dimerization.
Richard RE; Wood B; Zeng H; Jin L; Papayannopoulou T; Blau CA
Blood; 2000 Jan; 95(2):430-6. PubMed ID: 10627446
[TBL] [Abstract][Full Text] [Related]
19. Studies of the c-Mpl thrombopoietin receptor through gene disruption and activation.
Alexander WS; Roberts AW; Maurer AB; Nicola NA; Dunn AR; Metcalf D
Stem Cells; 1996; 14 Suppl 1():124-32. PubMed ID: 11012212
[TBL] [Abstract][Full Text] [Related]
20. Signal transduction by the receptors for thrombopoietin (c-mpL) and interleukin-3 in hematopoietic and nonhematopoietic cells.
Morella KK; Bruno E; Kumaki S; Lai CF; Fu J; Wang HM; Murray L; Hoffman R; Timour M; Bénit L
Blood; 1995 Jul; 86(2):557-71. PubMed ID: 7605989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
